位置:首页 > 蛋白库 > THNA_TRIHA
THNA_TRIHA
ID   THNA_TRIHA              Reviewed;        4043 AA.
AC   A0A0G0AID6;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2015, sequence version 1.
DT   03-AUG-2022, entry version 46.
DE   RecName: Full=Hybrid PKS-NRPS synthetase thnA {ECO:0000303|PubMed:33570538};
DE            EC=2.3.1.- {ECO:0000269|PubMed:33570538};
DE            EC=6.3.2.- {ECO:0000269|PubMed:33570538};
DE   AltName: Full=Trihazone biosynthesis cluster protein A {ECO:0000303|PubMed:33570538};
GN   Name=thnA {ECO:0000303|PubMed:33570538};
GN   ORFNames=THAR02_03179 {ECO:0000312|EMBL:KKP04699.1};
OS   Trichoderma harzianum (Hypocrea lixii).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Trichoderma.
OX   NCBI_TaxID=5544;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=T6776;
RX   PubMed=26067977; DOI=10.1128/genomea.00647-15;
RA   Baroncelli R., Piaggeschi G., Fiorini L., Bertolini E., Zapparata A.,
RA   Pe M.E., Sarrocco S., Vannacci G.;
RT   "Draft whole-genome sequence of the biocontrol agent Trichoderma harzianum
RT   T6776.";
RL   Genome Announc. 3:E0064715-E0064715(2015).
RN   [2]
RP   FUNCTION, DOMAIN, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=33570538; DOI=10.1039/d0ob02545c;
RA   Zhu Y., Wang J., Mou P., Yan Y., Chen M., Tang Y.;
RT   "Genome mining of cryptic tetronate natural products from a PKS-NRPS
RT   encoding gene cluster in Trichoderma harzianum t-22.";
RL   Org. Biomol. Chem. 19:1985-1990(2021).
CC   -!- FUNCTION: Hybrid PKS-NRPS synthetase; part of the gene cluster that
CC       produces the tetronate natural products trihazones (PubMed:33570538).
CC       The PKS-NRPS synthetase thnA with the help of the trans-enoyl reductase
CC       thnE are responsible for the synthesis of the carboxylmethyl containing
CC       trihazone A (PubMed:33570538). The PKS portion of thnA synthesizes
CC       beta-keto-triene chain from one acetyl-CoA and 6 equivalents of
CC       malonyl-CoA, in collaboration with thnE, which selectively reduces the
CC       enoyl intermediate during the first and fourth iteration of the PKS
CC       (PubMed:33570538). The NRPS domain selects and activates malate, of
CC       which the alpha-hydroxyl group attacks the completed polyketide acyl-S-
CC       ACP chain to form the ester product (PubMed:33570538). Intramolecular
CC       Dieckmann cyclization catalyzed by the terminal reductase domain
CC       releases the product as trihazone A from the PKS-NPRS
CC       (PubMed:33570538). The pathway begins with the formation of trihazone A
CC       by the hybrid PKS-NRPS synthetase thnA and the trans-enoyl reductase
CC       thnE. Trihazone A is further decarboxylated by the 2-oxoglutarate-
CC       dependent dioxygenase thnC to produce trihazone D. The function of the
CC       FAD-dependent monooxygenase thnD has still to be identified
CC       (PubMed:33570538). {ECO:0000269|PubMed:33570538}.
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:33570538}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. ThnA contains
CC       also a polyketide synthase module (PKS) consisting of several catalytic
CC       domains including a ketoacyl synthase domain (KS), an acyl transferase
CC       domain (AT), a dehydratase domain (DH), a methyltransferase domain
CC       (MT), and a ketoreductase domain (KR). Instead of a thioesterase domain
CC       (TE), traA finishes with a reductase-like domain (R) for peptide
CC       release. ThnA has the following architecture: KS-AT-DH-KR-PCP-C-A-T-R.
CC       {ECO:0000305|PubMed:33570538}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the NRP synthetase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JOKZ01000069; KKP04699.1; -; Genomic_DNA.
DR   EnsemblFungi; KKP04699; KKP04699; THAR02_03179.
DR   OMA; HSSDQIY; -.
DR   OrthoDB; 19161at2759; -.
DR   Proteomes; UP000034112; Unassembled WGS sequence.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 2.
DR   Gene3D; 3.10.129.110; -; 1.
DR   Gene3D; 3.30.300.30; -; 1.
DR   Gene3D; 3.30.559.10; -; 1.
DR   Gene3D; 3.40.366.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR013120; Far_NAD-bd.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR013217; Methyltransf_12.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR032821; PKS_assoc.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF00668; Condensation; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF08242; Methyltransf_12; 1.
DR   Pfam; PF07993; NAD_binding_4; 1.
DR   Pfam; PF00550; PP-binding; 2.
DR   Pfam; PF14765; PS-DH; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 2.
DR   SUPFAM; SSF47336; SSF47336; 2.
DR   SUPFAM; SSF51735; SSF51735; 2.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR   PROSITE; PS50075; CARRIER; 2.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE   1: Evidence at protein level;
KW   Ligase; Methyltransferase; Multifunctional enzyme; Oxidoreductase;
KW   Phosphopantetheine; Phosphoprotein; Reference proteome; Repeat;
KW   Transferase.
FT   CHAIN           1..4043
FT                   /note="Hybrid PKS-NRPS synthetase thnA"
FT                   /id="PRO_0000455675"
FT   DOMAIN          2434..2512
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:33570538"
FT   DOMAIN          3614..3695
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:33570538"
FT   REGION          9..443
FT                   /note="Ketosynthase (KS) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          558..894
FT                   /note="Malonyl-CoA:ACP transacylase (MAT) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          952..1256
FT                   /note="Dehydratase (DH) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          1417..1591
FT                   /note="Methyltransferase (MT) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          2146..2320
FT                   /note="Ketoreductase (KR) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          2521..2618
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2626..3067
FT                   /note="Condensation (C) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          3092..3496
FT                   /note="Adenylation (A) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   REGION          3736..3954
FT                   /note="Reductase (R) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:33570538"
FT   COMPBIAS        2533..2547
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2574..2605
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2472
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3655
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   4043 AA;  441739 MW;  95C213C5C8075C3F CRC64;
     MGSQNLEPIA IVGSACRFPG GVNSPSALWK LLEDPKDVCT DIPSDRFDTT GFYHPDGKHH
     GATNVRKSYL LQEDLRLFDT AFFNISPNEA DSMDPQQRIL LETVYEALEA GGHTMESLRG
     SDTAVFTGTM GVDYNDTGIR DLNTVPTYFA TGVNRAIISN RVSYFFDWHG PSMTIDTACS
     SSLIAVHQAV KALRTDESRV ALACGTQVIL NPEMYVIESK LKMLSPTGRS RMWDADADGY
     ARGEGMAAIV LKRLSDAIAD GDHIECLIRH TGSNQDGYSN GITVPSTEAQ AALIRQTYAQ
     AGLDPERCAE DSPQFFEAHG TGTKAGDPKE AAAIYHSFGR HKSAGDTPLY VGSIKTVIGH
     LEGSAGLAGL LKASGSIQNG VIAPNLLFQR LNPDIEPFYK GLQVPTKVIP WPQLPAGVPR
     RASVNSFGFG GSNAHAILEE YRGPSGQSEG TSGSQDGAIF TPFVFSAFSE SSLVAQLRAT
     ADYLRTQQEK VNAKDLAWTL QSRRSQFPTK LALSALNIEE LVSKIDAKLA PLAQNPNIAI
     GTKASSKAAS AGPKILGVFT GQGAQWASMG AELIRSSAFV AKRIDELEQS LAALPASDRP
     QWSLKAEIMA NSDTSRIGEA ALSQPLCTAI QVVLVDLLQS AGISFSAVVG HSSGEIAAAY
     AAGFFSANDA VRIAYYRGLH ARLAGNASTG QSGAMIAVGT SWEDAQDLIS LRAFKGRLAV
     AAHNSAASVT LSGDADAVAH AKRVFDDEKK FARVLKVDTA YHSHHMLPCG DPYISSLQSC
     VIQINKTRKD NSCAWFSSVT PSSQGMEPID ALKDTYWRDN MTNAVLFADA VKNAVASDEQ
     LSLVLEVGPH PALKGPATQN IADVRPSPIP YSGVLSRGAN DVNAFSDALG FVWTHFGSQH
     VDFQSYTKLV SDGERQPKLV VGLPSYQWNH ARLHWNESRR SKRLRGRKQA THEILGTILP
     ESTPQDLRWS NILKVSEMPW MEGHQLQGQT VFPAAGYIAM ALEASKFLAA DKEVKVFEVN
     DLAIPRAVTF EEGDTSGVET LVTLTDIRQH QNKYLAANFS CYSLPVLSSG SEQEMDLIAT
     ATVKIILGTP SVESLMAPPA EDYNLFPIDA DRFYTTLEGL GYGYSGPFKA FSSMQRRLDY
     ATGQVATYVY SEDDTSPYLF HPSTLDVAFH AAMLAYSSPG DERLWSLHVP TGIRSVRVNP
     ALCSLLPATG TRLPVRASID GTSTSFSGYV DLLSEDGEYS AVQIEDLSIK TFAPATQADD
     RVLFTHTKLD IAGPDGAAVA EGVRPTALEK ELAHACERMA YFYVRKWNSE LSDDEWANGQ
     PHYKYLHDWV KRTLDLAKKG QHPTLQRKWA NDTAEEINAL MDQYPDNLDV KMIRTVGEKI
     PPAVRNETTI LEHLLQDNML DDFYKLGSGF QRYNQFLASM MKQITHRYPH TKILEIGAGT
     GGATKYLLKA MGDKMASYTY TDISLGFFGK AAEIFKEYSD KMTFKVLDVE KSPAAQGYEQ
     HSYDIVIASN VLHATESLHT TLVNTRKLLK PGGYLLLLEI TNNNPIRTGL IWGTFAGWWL
     GVEDGRRWAP TISPGQWHSA LRKAGFAGVD AVTPEIDTVA WPFSIMASQA VDDRVTFLRQ
     PLSSLSPPIH IESLVILGNQ SLQTARLAEE LADNLRRFCG ELTILDSLPT DEESLDLAPQ
     STFINLVDID SPIFKDITSE GMGGLQRMFE LAKHVLWITS GALIEEPYHM SSITFSRVVR
     RESGHINLAH LDVSDLQQSD VPKAISKHLL QLVALDEWET PAIGADGQED QQRILWSKES
     EAFLENGTLL LPRLVNNVEQ NARLNSARRT IYKEVPIRSP TVTLIPPSAT SPPSLAEPTS
     LVPRRSDNLL WVDSSSLMAL NVASDSYLFL AVSKEDATGR PLLLLSTTNS VAMAPVATLE
     APMDAKTYVK NPSESSSRLL VTAASEILAS SLIDRLSPGS SVLVHCSNKD RFLAAALSRR
     ASPAAVMFTF TFDADDKSGT ENSAWVPLSG RASNYGIRKA MPSAKPTHFL DLTAGTGLGL
     RISQLLPPTC HHIEISSLVR NESTVASSCD PDTLTNHLRE TCLGDELTSA LASEQRELKD
     LIIAADHLDT SATYHATSAV FWPSTGLVKV GVSSIDSTGL FSRDKTYLLV GLTGKIGQSI
     AKWLVANGAG CVCLMSRNPN IEPAWIESFQ GTGGDVKIYS MDSTDITSVE TVMNEIRTTC
     PPIGGVAHGS MVLHDSLFSK MTVEDMQTVL APKIDGAIYL DQLFYDDDLD FFVLFSSAAC
     VVGNLGQANY AAANGYLNSL SRQRRRRGVA GSTFDIGQVA GVGYIESAGQ IVMDQLSALG
     LQRLSEADLQ QVFAETIRAG RPDPKDAETT PFAVVTSGIR NFSEDENIKG PWFTNPFFSH
     CVIDAKVAEL ESDSSDKKSN IPAARQLVKA TSLEQALDIL KECFATKLRV ILQLGSQDID
     YDAPLVELGI DSLVAVEVRS WFLKEVRVDI PVLKVVGGAS LAELCDRVVD KLPEELLVSV
     GKQGESQPPA STAQPQPVAP KPKPLPVPSF VVDSNGPPSE VSVSPAGTPL LSAGPASYSA
     TEASTRSGSP SEATRLSQKV SSKLQSYFPP PPEPAVERKR PAKRFIKSVP ISLGQSRFWF
     LQQLLDDQRT HNVAYYYHIK GNLDVGDMER AVRLVASRHE ALRTCFVQDE TDASQAYQKV
     LPSSPVRLIC KKIDSEDDVA SEYQRLRAHD LDMASGELLK LVLLTLSPSS HFLLMYHHHI
     IMDGISLQVF LSDLEKAYKG ESLGPAPKQY PDFSKAQRQA FENGEMKKEL AFWRRIFPDG
     EQPPVLPLLP MARTNARVPM AKFDTHQVQA RVDAALAAKV RTVAKQQRST PFHLYLAAFK
     ALLFCFTDVD ELTIGVADGA RHDSSLMGSI GFFLNLLTLR FRRQPNQPFT EAIAEARKIS
     HAALENSRVP FDVLLSELNV ARSSTYSPFF QAFIDYRQGH QEEQTWGNCQ MRMSEEVHTG
     KTAYDITVDV TETDAAAFIF FRGQKSIYDQ EATQLLCDTY VHFLEVLTKE PSLAMSAIPR
     FSEKQLAEAI QVGRGPKLVS DWPETLPLRI DQVARENPDK VALMDGTGKA LTYASMINRI
     HSIAEALQEA GVGPGLRVLV FQQATSDWPC SMLAIMRLGA IYVPLDLRNP LPRLAAVAQD
     CEPTAILADA STLDEASQLG VPSARLIDVS LVKTNPSKEV SNDSRAHSTA AILYTSGSTG
     TPKGIMVTHE GLRNEIEGYT KTWKLGPERV LQQSAFTFNH SSDQIYTGLV NGGMVYVVPW
     DKRGNALEIT KIIQEQGITY TKATPSEYSL WMLYGRESLR LATSWRCAFG GGESLTTTVT
     QQFADLDLPQ LHFFNSYGPT EISISSTKME IPYRDREALE RVGRIPCGYS LPGYYMYAVD
     EELRPLPAGM PGQLCIGGTG VSLGYLKNQE LTDKHFLPNP FATEEDIANG WTRMYLTGDI
     GHMNQDGTMV FHSRMAGDTQ VKIRGLRIEL SDIESNIVAA SQGALREAVV TLREGDPEFL
     VAHVVFVPEC TIADKETFLQ QLLHNLPVPQ YMIPVVAIPI DELPLTNHSK VDRKAVKSLP
     LPHRVDRPDT SDDTELTETM IQLKGLWRGV LGKAIDQLGF DITPFTSFFL VGGNSLLIIR
     LQSEIRKRFR AAVPLVELLG ANTLGEMAQK VEETISVKTI DWEYDTRPPT ISASAIASAI
     ASVPIDRARK GSTIVITGAT GFLSKHLLPM LDARTDVDVI HCLAVRDIER AYSSPKVIHH
     SGDLSSPLLG LSNDEFNELS GTADAILHMG AARSFWDSYH VLRPINVAPT SDLVKLAAPR
     RVPIHYISTA SLFGGTTATL DGSAVSAAAY PPPTDGSSGY AATRWASERI LERSAADLGV
     PSSIYRLCPA TTRQDAPQAL LDEFTHYGSI IRATPDLSGW SGRLDMLPAV LTAQWLCEAL
     LNYEERSGIV QFRNYESLLT VTGAELTASF DQEQSGSGNL EKISLLKWIG KIKKAGFPYF
     LASHEIAIEK EGSVNDTKLE MRR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024